Your browser doesn't support javascript.
loading
Bruton's tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome.
Kröller, Sarah; Wissuwa, Bianka; Dennhardt, Sophie; Krieg, Nadine; Thiemermann, Christoph; Daniel, Christoph; Amann, Kerstin; Gunzer, Florian; Coldewey, Sina M.
Afiliación
  • Kröller S; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Wissuwa B; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Dennhardt S; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Krieg N; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Thiemermann C; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Daniel C; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Amann K; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Gunzer F; Septomics Research Center, Jena University Hospital, Jena, Germany.
  • Coldewey SM; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Front Immunol ; 14: 1105181, 2023.
Article en En | MEDLINE | ID: mdl-36911665
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Escherichia coli Shiga-Toxigénica / Lesión Renal Aguda / Síndrome Hemolítico-Urémico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Escherichia coli Shiga-Toxigénica / Lesión Renal Aguda / Síndrome Hemolítico-Urémico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Alemania